SOUTHERN CO

SOJF

Held by 2 specialist biotech funds

Share on X

Fund Holdings

Driehaus Capital Eventide Asset Management

AI Signal

AI analyst context — unlock full analysis

Position Trend

Feb 13, 2026

$9.7M

1 fund

Feb 17, 2026

$69.8M

1 fund

+620% total institutional value over 2 quarters

Catalysts

No catalysts tracked.

Position Details

Driehaus CapitalNEWFeb 17, 2026

Shares: 486,393Value: $69.8M

**Signal Note: Driehaus Initiates Southern Company Position** This $69.8M position initiation by a growth-focused biotech allocator in a utility company is atypical and likely reflects conviction in non-core biotech assets or a strategic pivot—Southern Company has minimal direct biotech exposure. Without clarity on the underlying catalyst, this move warrants monitoring for potential M&A activity, licensing deals, or undisclosed partnerships involving Southern Company subsidiaries in healthcare/cleantech sectors.

Eventide Asset ManagementNEW

Know which insider moves are real

See who's buying with their own money vs. routine exercises
AI explains why each move matters right now

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

AXON2 funds NVDA2 funds VEEV2 funds VCYT2 funds LBRT2 funds RMBS2 funds UNP2 funds LITE

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief:

**Signal Note: Eventide initiates Southern Company position** This $9.7M position in Southern Company (SO) appears inconsistent with Eventide's biotech-focused mandate and values-based strategy, suggesting either portfolio diversification into utilities/clean energy or a data error. The position size (~0.1% of typical biotech holdings) and timing warrant clarification on whether this reflects ESG criteria alignment (renewable energy transition) or represents a portfolio rebalancing outside core competencies.